The effect of low-dose and high-dose low-molecular-weight-heparin and aspirin thromboprophylaxis on clinical outcome and mortality in critical ill patients with COVID-19: A retrospective cohort study

dc.date.accessioned	2023-03-06T07:32:55Z
dc.date.available	2023-03-06T07:32:55Z
dc.date.issued	2022
dc.identifier.citation	Saudi Med J. 2022 Jul;43(7):715-722. doi: 10.15537/smj.2022.43.7.20220038.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/100483
dc.relation.isversionof	10.15537/smj.2022.43.7.20220038
dc.relation.isversionof	10.15537/smj.2022.43.7.20220038
dc.title	The effect of low-dose and high-dose low-molecular-weight-heparin and aspirin thromboprophylaxis on clinical outcome and mortality in critical ill patients with COVID-19: A retrospective cohort study
dc.relation.journal	Saudi Med J
dc.identifier.doi	10.15537/smj.2022.43.7.20220038
dc.contributor.author	Eman A
dc.contributor.author	Eman A
dc.contributor.author	Balaban O
dc.contributor.author	Süner KÖ
dc.contributor.author	Cırdı Y
dc.contributor.author	Şahin F
dc.contributor.author	Demir G
dc.contributor.author	Pekşen Ö